logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (i) Outpatient units

Primary drugMalesFemalesTotal
Mean age at first useMean age at entering treatmentTime lag between first use and first treatment demandMean age at first useMean age at entering treatmentTime lag between first use and first treatment demandMean age at first useMean age at entering treatmentTime lag between first use and first treatment demand
Opiods22331122308223210
Cocaine223192330722319
Stimulants202881926720277
Cannabis172471724717247

Notes:

 Countries included are: BE, BG, CZ, DK, DE, EE, IE, EL, ES, FR, IT, CY, LV, LT, HU, MT, NL, AT, RO, SI, SK,FI, SE, HR 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010